In March 2010, the district court for the Southern District of New York held that “isolated DNA” does not qualify as patentable subject matter under 35 USC §101. Ass’n for Molecular Pathology and ACLU v. USPTO and Myriad (S.D.N.Y 2010). While the decision was groundbreaking and un-nerving for biotechnology and pharmaceutical companies, the overall consensus [...]

We have received a reader question from our August Newsletter http://mkgip.com/ajax/EmailPreview.php?RF_ITEM[]=Email$0@16;Email The reader asks:                 My company develops special formulations for customers that are typically using virgin plastic resins.  We replace that material with ours which contains various biomass, i.e., corncobs, sunflower hulls.  My question is how do we protect our formulations from competitors in [...]